EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Innovative Therapeutic Strategies in Alzheimer’s Disease: A Synergistic Approach to Neurodegenerative Disorders

Sarfaraz K Niazi iD, Matthias Magoola, Zamara Mariam iD

Pharmaceuticals · 06.06.2024 · 17 (6) · 741

DOI: 10.3390/ph17060741 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 06.06.2024. Verfasst von Sarfaraz K Niazi und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, University of Illinois, Chicago, IL 60012, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) remains a significant challenge in the field of neurodegenerative disorders, even nearly a century after its discovery, due to the elusive nature of its causes. The development of drugs that target multiple aspects of the disease has emerged as a promising strategy to address the complexities of AD and related conditions. The immune system’s role, particularly in AD, has gained considerable interest, with nanobodies representing a new frontier in biomedical research. Advances in targeting antibodies against amyloid-β (Aβ) and using messenger RNA for genetic translation have revolutionized the production of antibodies and drug development, opening new possibilities for treatment. Despite these advancements, conventional therapies for AD, such as Cognex, Exelon, Razadyne, and Aricept, often have limited long-term effectiveness, underscoring the need for innovative solutions. This necessity has led to the incorporation advanced technologies like artificial intelligence and machine learning into the drug discovery process for neurodegenerative diseases. These technologies help identify therapeutic targets and optimize lead compounds, offering a more effective approach to addressing the challenges of AD and similar conditions.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseantibody targetingblood–brain barrierchemical targetingmRNA vaccinenanobodiesneurodegenerative diseases

Autor:innen und Institutionen

  • College of Pharmacy, University of Illinois, Chicago, IL 60012, USA.
  • DEI Biopharma, Kampala P.O. Box 35854, Uganda.
  • Centre for Health and Life Sciences, Coventry University, Coventry CV1 5FB, UK.

ORCID-Profile: Sarfaraz K Niazi, Zamara Mariam

Zitieren

APA

Niazi, S. K., Magoola, M., & Mariam, Z. (2024). Innovative Therapeutic Strategies in Alzheimer’s Disease: A Synergistic Approach to Neurodegenerative Disorders. Pharmaceuticals, 17(6), 741. https://doi.org/10.3390/ph17060741

Vancouver

Niazi SK, Magoola M, Mariam Z. Innovative Therapeutic Strategies in Alzheimer’s Disease: A Synergistic Approach to Neurodegenerative Disorders. Pharmaceuticals. 2024;17(6):741. doi:10.3390/ph17060741

BibTeX
@article{Niazi2024,
  author = {Niazi, Sarfaraz K and Magoola, Matthias and Mariam, Zamara},
  title = {Innovative Therapeutic Strategies in Alzheimer’s Disease: A Synergistic Approach to Neurodegenerative Disorders},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {6},
  pages = {741},
  doi = {10.3390/ph17060741}
}
Kostenlos starten →